Page 160 - Vitamin D and Cancer
P. 160

7  Induction of Differentiation in Cancer Cells by Vitamin D    147

            have been identified, and these include changes in “transepithelial electrical resistance”
            and ubiquitin, as based on matrix-assisted laser desorption/ionization time-of-flight
            mass spectrometry (MALDI-TOFMS). The latter procedure generates specific mass
            spectral fingerprints characteristics of cell differentiation, and it was suggested that
            ubiquitin can be a marker of differentiation of the T84 human colon carcinoma cell
            line [28]. In another colon cancer cell line, SW80, 1,25D was shown to induce easily
            recognizable morphological changes indicative of differentiated epithelial-like phe-
            notype [29]. These morphological changes include consequences of the adherence
            to the culture substratum, which make the cells look flat and polygonal, and it was
            demonstrated  that  these  cells  have  reduced  tumorigenicity  when  implanted  into
            athymic mice. Thus, the epidemiological data which indicate that 1,25D has a nega-
            tive effect on the incidence of human colorectal cancer [30, 31] are well supported
            by the in vitro studies of 1,25D-induced differentiation of colon carcinoma cell lines.
              How 1,25D signals differentiation of colon cancer cells is not entirely clear, but
            several groups of key molecules have been identified that appear to govern this
            process, and an outline of their postulated interactions is integrated in Fig. 7.1.


                                         1,25D

                                  Ca 2+      Wnt
                                                            E-cadherin
                       EGFR           Frizzled              β-catenin


                      Ras         Ca 2+
                                                APC
                                 PKC α     β-catenin         VDR
                JNK 1/2   Raf-1                                β-catenin
                                    DEGRADATION
                c-jun   MEK 1/2
                               Sp1
                 AP1    Erk 1/2   ?
                      ?
                    fos
                            CoA   VDR        β-catenin
                                                  TCF4        c-myc

                          DIFFERENTIATION
                          APOPTOSIS                       PROLIFERATION
                          GROWTH INHIBITION
            Fig. 7.1  The suggested pathways of 1,25D-induced differentiation in colon cancer. In proliferating
            colon epithelial cells, the b-catenin complexed with TCF-4 drives the expression of growth promoting
            genes such as c-myc. This is under the control of Wnt and its surface receptor Frizzled, which
            inactivate GSK-3b (not shown) and allow the accumulation of b-catenin and thus growth promo-
            tion. Binding of b-catenin by VDR, or by other proteins including E-cadherin, the expression of
            which is induced by 1,25D (formula shown) leads to the loss of b-catenin from the transcriptional
            complex in the nucleus and, as a consequence, decreased cell proliferation. Also shown is the acti-
            vation of PKCa by 1,25D-induced influx of calcium (Ca ) which can activate by phosphorylation
                                                  2+
            the transcriptional activity of VDR and repression of EGFR by 1,25D in colon-derived cells
   155   156   157   158   159   160   161   162   163   164   165